These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21139283)

  • 21. [Therapy for gout and pseudogout].
    Taniguchi A
    Nihon Naika Gakkai Zasshi; 2008 Oct; 97(10):2424-9. PubMed ID: 19149040
    [No Abstract]   [Full Text] [Related]  

  • 22. Allopurinol, benzbromarone and risk of coronary heart disease in gout patients: A population-based study.
    Lin HC; Daimon M; Wang CH; Ho Y; Uang YS; Chiang SJ; Wang LH
    Int J Cardiol; 2017 Apr; 233():85-90. PubMed ID: 28202260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stopping progression to tophaceous gout. When and how to use urate-lowering therapy.
    McDonald E; Marino C
    Postgrad Med; 1998 Dec; 104(6):117-20, 123-4, 127. PubMed ID: 9861261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Updates on the treatment of gout, including a review of updated treatment guidelines and use of small molecule therapies for difficult-to-treat gout and gout flares.
    Soskind R; Abazia DT; Bridgeman MB
    Expert Opin Pharmacother; 2017 Aug; 18(11):1115-1125. PubMed ID: 28658988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and management of gout.
    Underwood M
    BMJ; 2006 Jun; 332(7553):1315-9. PubMed ID: 16740561
    [No Abstract]   [Full Text] [Related]  

  • 26. [What is certain in gout therapy?].
    Gottesbüren H; Strohmeyer G
    Internist (Berl); 1971 Dec; 12(12):518-21. PubMed ID: 4945391
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of gout].
    Dubost JJ; Mathieu S; Soubrier M
    Rev Med Interne; 2011 Dec; 32(12):751-7. PubMed ID: 21382654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperuricaemia and gout: clinical guideline 2003.
    Meyers OL; Cassim B; Mody GM
    S Afr Med J; 2003 Dec; 93(12 Pt 2):961-71. PubMed ID: 14763409
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of hyperuricemia and gout].
    Gröbner W; Walter-Sack I
    Med Monatsschr Pharm; 2005 May; 28(5):159-64; quiz 165-6. PubMed ID: 15912988
    [No Abstract]   [Full Text] [Related]  

  • 30. Successful treatment of refractory gout using combined therapy consisting of febuxostat and allopurinol in a patient with chronic renal failure.
    Maekawa M; Tomida H; Aoki T; Hishida M; Morinaga T; Tamai H
    Intern Med; 2014; 53(6):609-12. PubMed ID: 24633032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On call. I've had gout for many years. I used to take Zyloprim without any problems, but I just had a severe allergic reaction, so my doctor switched me to Benemid. I'm doing okay, but the drug sometimes upsets my stomach. Do you have any suggestions?
    Simon HB
    Harv Mens Health Watch; 2010 Jan; 14(6):7-8. PubMed ID: 20464796
    [No Abstract]   [Full Text] [Related]  

  • 32. Treating gout in kidney transplant recipients.
    Baroletti S; Bencivenga GA; Gabardi S
    Prog Transplant; 2004 Jun; 14(2):143-7. PubMed ID: 15264458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The safety and efficacy of benzbromarone in gout in Aotearoa New Zealand.
    Stamp LK; Haslett J; Frampton C; White D; Gardner D; Stebbings S; Taylor G; Grainger R; Kumar R; Kumar S; Kain T; Porter D; Corkill M; Cathro A; Metcalfe S; Wyeth J; Dalbeth N
    Intern Med J; 2016 Sep; 46(9):1075-80. PubMed ID: 27391386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [How to select and use urate lowering agents for hyperuricemia].
    Yamanaka H
    Nihon Rinsho; 1996 Dec; 54(12):3261-5. PubMed ID: 8976102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic approaches in the treatment of gout.
    Pillinger MH; Mandell BF
    Semin Arthritis Rheum; 2020 Jun; 50(3S):S24-S30. PubMed ID: 32620199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of hyperuricemia, gout and other crystalline arthritidies.
    Lioté F
    Reumatismo; 2012 Jan; 63(4):276-83. PubMed ID: 22303534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2011 Recommendations for the diagnosis and management of gout and hyperuricemia.
    Hamburger M; Baraf HS; Adamson TC; Basile J; Bass L; Cole B; Doghramji PP; Guadagnoli GA; Hamburger F; Harford R; Lieberman JA; Mandel DR; Mandelbrot DA; McClain BP; Mizuno E; Morton AH; Mount DB; Pope RS; Rosenthal KG; Setoodeh K; Skosey JL; Edwards NL;
    Postgrad Med; 2011 Nov; 123(6 Suppl 1):3-36. PubMed ID: 22156509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. International position paper on the appropriate use of uricosurics with the introduction of lesinurad.
    Jansen TL; Perez-Ruiz F; Tausche AK; Richette P
    Clin Rheumatol; 2018 Dec; 37(12):3159-3165. PubMed ID: 30244431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Introduction of the new guideline for the management of hyperuricemia and gout with special reference to its policy].
    Nakajima H; Matsuzawa Y
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():442-9. PubMed ID: 12629763
    [No Abstract]   [Full Text] [Related]  

  • 40. Diagnostic and therapeutic aids in gout and hyperuricemia.
    Bollet AJ
    Med Times; 1981 Aug; 109(8):23-31. PubMed ID: 7278540
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.